Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 04:16, 17 September 2019
   
Page name:

16 September 2019

 m   23:20  Acute myeloid leukemia‎‎ (2 changes | history) . . (+596). . [Jwarner‎ (2×)]
 m    23:20 (cur | prev) . . (+75). . Jwarner (talk | contribs) (References)
 m    17:20 (cur | prev) . . (+521). . Jwarner (talk | contribs) (References)

15 September 2019

     21:14  Acute myeloid leukemia‎‎ (9 changes | history) . . (+4,052). . [Jwarner‎ (9×)]
 m    21:14 (cur | prev) . . (+731). . Jwarner (talk | contribs) (MEC {{#subobject:324735|Regimen=1}})
 m    16:10 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m    10:02 (cur | prev) . . (+746). . Jwarner (talk | contribs) (7+3i {{#subobject:717935|Regimen=1}})
 m    09:54 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #3, 100/13, CI Ara-C {{#subobject:7f2eec|Variant=1}})
 m    09:49 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #2, 100/12, CI Ara-C {{#subobject:c6cda|Variant=1}})
 m    09:34 (cur | prev) . . (+913). . Jwarner (talk | contribs) (7+3d & GO {{#subobject:869f84|Regimen=1}})
 m    09:32 (cur | prev) . . (+19). . Jwarner (talk | contribs) (Variant #1, CI Ara-C (100 mg/m2) {{#subobject:bb27bc|Variant=1}})
 m    09:29 (cur | prev) . . (+551). . Jwarner (talk | contribs) (References)
      09:28 (cur | prev) . . (+1,083). . Jwarner (talk | contribs) (HiDAC {{#subobject:1dddf5|Regimen=1}})
     17:04  Chronic lymphocytic leukemia‎‎ (3 changes | history) . . (+1,562). . [Jwarner‎ (3×)]
      17:04 (cur | prev) . . (+1,545). . Jwarner (talk | contribs) (FCR {{#subobject:1dc12c|Regimen=1}})
 m    08:56 (cur | prev) . . (+15). . Jwarner (talk | contribs) (Alemtuzumab monotherapy {{#subobject:ab5318|Regimen=1}})
 m    08:55 (cur | prev) . . (+2). . Jwarner (talk | contribs) (Regimen {{#subobject:54cc87|Variant=1}})
 m   16:44  Chronic myelogenous leukemia‎ (diff | hist) . . (+947). . Jwarner (talk | contribs) (Vincristine & Prednisone {{#subobject:7d31e7|Regimen=1}})
 m   16:07  Myelofibrosis‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)

14 September 2019

 m   14:06  Acute myeloid leukemia‎ (diff | hist) . . (+588). . Jwarner (talk | contribs) (7+3m {{#subobject:240c72|Regimen=1}})
 m   10:41  Chronic myelogenous leukemia‎‎ (2 changes | history) . . (+2,805). . [Jwarner‎ (2×)]
 m    10:41 (cur | prev) . . (+1,513). . Jwarner (talk | contribs) (Interferon alfa-2a monotherapy {{#subobject:78hjbj|Regimen=1}})
 m    08:37 (cur | prev) . . (+1,292). . Jwarner (talk | contribs)

13 September 2019

 m   23:45  Chronic lymphocytic leukemia‎‎ (3 changes | history) . . (-497). . [Jwarner‎ (3×)]
 m    23:45 (cur | prev) . . (-2). . Jwarner (talk | contribs)
 m    14:34 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Variant #2, 6 cycles {{#subobject:d30c3f|Variant=1}})
 m    14:31 (cur | prev) . . (-500). . Jwarner (talk | contribs)
 m   21:07  Folinic acid (Leucovorin)‎ (diff | hist) . . (+165). . Jwarner (talk | contribs) (History of changes in FDA indication)
 m   19:52  Myelodysplastic syndrome‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Variant #2, 15 mg/m2, 3 days per cycle (IV) {{#subobject:9303da|Variant=1}})
 m   17:33  Chronic myelogenous leukemia‎‎ (2 changes | history) . . (+20). . [Jwarner‎ (2×)]
 m    17:33 (cur | prev) . . (+10). . Jwarner (talk | contribs) (Omacetaxine monotherapy {{#subobject:fb80ac|Regimen=1}})
 m    11:16 (cur | prev) . . (+10). . Jwarner (talk | contribs)

12 September 2019

 m   22:53  Chronic lymphocytic leukemia‎‎ (4 changes | history) . . (+35). . [Jwarner‎ (4×)]
 m    22:53 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m    11:29 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:5cabd0|Variant=1}})
 m    11:27 (cur | prev) . . (+23). . Jwarner (talk | contribs)
 m    11:02 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Regimen {{#subobject:8e168d|Variant=1}})
 m   22:09  Chronic myelogenous leukemia‎ (diff | hist) . . (+983). . Jwarner (talk | contribs)

11 September 2019

 m   22:50  Myelofibrosis‎ (diff | hist) . . (+6). . Jwarner (talk | contribs) (Ruxolitinib monotherapy {{#subobject:6 |Regimen=1}})
 m   18:04  Chronic lymphocytic leukemia‎ (diff | hist) . . (+6). . Jwarner (talk | contribs)
 m   16:59  Chronic myelogenous leukemia‎‎ (4 changes | history) . . (+1,180). . [Jwarner‎ (4×)]
 m    16:59 (cur | prev) . . (+1,167). . Jwarner (talk | contribs) (Dasatinib monotherapy {{#subobject:51eb88|Regimen=1}})
 m    16:53 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Dasatinib monotherapy {{#subobject:a47c6c|Regimen=1}})
 m    16:52 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Variant #2, 100 mg/day {{#subobject:c86ad6|Variant=1}})
 m    16:50 (cur | prev) . . (+4). . Jwarner (talk | contribs) (Regimen {{#subobject:2dc029|Variant=1}})
 m   15:58  Acute myeloid leukemia‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Regimen {{#subobject:0b4cdf|Variant=1}})

10 September 2019

 m   11:11  Chronic lymphocytic leukemia‎ (diff | hist) . . (+3). . Jwarner (talk | contribs) (Regimen {{#subobject:a166c6|Variant=1}})
 m   10:36  Chronic myelogenous leukemia‎‎ (2 changes | history) . . (+12). . [Jwarner‎ (2×)]
 m    10:36 (cur | prev) . . (+9). . Jwarner (talk | contribs)
 m    10:34 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #1, 400 mg/day {{#subobject:eb73f2|Variant=1}})